The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens

This publication has 25 references indexed in Scilit:

• Evaluation of optimal survival of primitive progenitor cells (LTC-IC) from PBPC apheresis products after overnight storage
  Bone Marrow Transplantation, 2000
• Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens
  Bone Marrow Transplantation, 1999
• Changes in L-selectin expression on CD34-positive cells upon cryopreservation of peripheral blood stem cell transplants
  Bone Marrow Transplantation, 1998
• Recombinant human granulocyte and granulocyte–macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells
  Bone Marrow Transplantation, 1998
• Mobilization and homing of peripheral blood progenitors is related to reversible downregulation of alpha4 beta1 integrin expression and function.
  Journal of Clinical Investigation, 1998
• GM-CSF-mobilized peripheral blood CD34+ cells differ from steady-state bone marrow CD34+ cells in adhesion molecule expression
  Bone Marrow Transplantation, 1997
• In Vitro Growth of Mobilized Peripheral Blood Progenitor Cells is Significantly Enhanced by Stem Cell Factor
  Stem Cells, 1997
• High-dose melphalan with re-infusion of unprocessed, G-CFS-primed whole blood is effective and non-toxic therapy in multiple myeloma
  European Journal of Cancer, 1996
• Differential expression of cell adhesion molecules by human hematopoietic progenitor cells from bone marrow and mobilized adult peripheral blood
  Stem Cells, 1995
• Characterization of enriched CD34 ⁺ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony‐stimulating factor (G‐CSF)
  Stem Cells, 1995